A new drug for pulmonary fibrosis has reduced disease progression by more than 50% over a 52-week treatment in two clinical ...

Researchers are working to redefine diagnosis and treatment with data-driven tools aimed at identifying patients earlier and ...

chest pain or circulatory problems are confused with those of other heart and lung diseases. Because the chronically elevated blood pressure in the pulmonary circulation also puts a strain on the ...

The Program for Pulmonary Fibrosis and Interstitial Lung Disease's mission is to provide state of the art evaluation and treatment for patients with interstitial lung diseases (ILD). The University of ...

The combination of antifibrotic therapy and pulmonary vasodilator therapy improved transplant-free survival but had no ...

Elevated pressures in the pulmonary circulation are due to left-sided heart diseases such as heart failure or valvular ...

Researchers at Baylor College of Medicine and collaborating institutions have uncovered a key molecular player that is ...

I graduated from the University of Edinburgh in 1991 and undertook a period of postgraduate research in Dundee examining the effects of hypoxia, hypercapnia and vasoactive peptides on the pulmonary ...